Citations (72)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Asim Biswas, Rahul Shubhra Mandal, Suparna Chakraborty & George Maiti. (2022) Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population. International Reviews of Immunology 41:4, pages 448-463.
Read now
Read now
Nirmal Marasini & Lisa M. Kaminskas. (2019) Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?. Drug Development and Industrial Pharmacy 45:6, pages 882-894.
Read now
Read now
Anshu Malik, Manish Gupta, Vatika Gupta, Himanshu Gogoi & Rakesh Bhatnagar. (2018) Novel application of trimethyl chitosan as an adjuvant in vaccine delivery. International Journal of Nanomedicine 13, pages 7959-7970.
Read now
Read now
Hermann Giresse Tima, Kris Huygen & Marta Romano. (2016) Innate signaling by mycobacterial cell wall components and relevance for development of adjuvants for subunit vaccines. Expert Review of Vaccines 15:11, pages 1409-1420.
Read now
Read now
Christian Herzog. (2014) Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature. Expert Review of Vaccines 13:3, pages 399-415.
Read now
Read now
Tehila Mayer-Sonnenfeld, Michael Har-Noy, Kevin O. Lillehei & Michael W. Graner. (2013) Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure. International Journal of Hyperthermia 29:6, pages 520-527.
Read now
Read now
Christian Moser, Matthias Müller, Matthias D Kaeser, Ulrike Weydemann & Mario Amacker. (2013) Influenza virosomes as vaccine adjuvant and carrier system. Expert Review of Vaccines 12:7, pages 779-791.
Read now
Read now
Joseph U Igietseme, Francis O Eko & Carolyn M Black. (2011) Chlamydia vaccines: recent developments and the role of adjuvants in future formulations. Expert Review of Vaccines 10:11, pages 1585-1596.
Read now
Read now
Franco M Buonaguro, Maria Lina Tornesello & Luigi Buonaguro. (2011) New adjuvants in evolving vaccine strategies. Expert Opinion on Biological Therapy 11:7, pages 827-832.
Read now
Read now
Articles from other publishers (63)
Francisco Noé Fonseca, Vanessa Haach, Franciana Volpato Bellaver, Gabrielly Bombassaro, Danielle Gava, Luciano Paulino da Silva, Lana Flavia Baron, Mayara Simonelly, Wanessa Araújo Carvalho, Rejane Schaefer & Ana Paula Bastos. (2023) Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine. Virology Journal 20:1.
Crossref
Crossref
Gerrit Koopman, Mario Amacker, Toon Stegmann, Ernst J. Verschoor, Babs E. Verstrepen, Farien Bhoelan, Denzel Bemelman, Kinga P. Böszörményi, Zahra Fagrouch, Gwendoline Kiemenyi-Kayere, Daniella Mortier, Dagmar E. Verel, Henk Niphuis, Roja Fidel Acar, Ivanela Kondova, Yolanda S. Kap, Willy M. J. M. Bogers, Petra Mooij & Sylvain Fleury. (2023) A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge. Scientific Reports 13:1.
Crossref
Crossref
Nathalie Garçon & Martin Friede. 2023. Plotkin's Vaccines. Plotkin's Vaccines
77
90.e4
.
Walid Azab. 2023. Antimicrobial Activity of Nanoparticles. Antimicrobial Activity of Nanoparticles
133
154
.
H. M. Treshalina, M. A. Baryshnikova, E. V. Neborak & V. S. Kosorukov. (2022) Peptide antitumor vaccines targeting HER2/neu. Russian Journal of Biotherapy 21:4, pages 22-29.
Crossref
Crossref
Agustín Valenzuela-Fernández, Romina Cabrera-Rodriguez, Laura Ciuffreda, Silvia Perez-Yanes, Judith Estevez-Herrera, Rafaela González-Montelongo, Julia Alcoba-Florez, Rodrigo Trujillo-González, Diego García-Martínez de Artola, Helena Gil-Campesino, Oscar Díez-Gil, José M. Lorenzo-Salazar, Carlos Flores & Jonay Garcia-Luis. (2022) Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Hong Bian, Qing-Li Dou, Jian Wei, Jing-Le Liu, Xiao Wang & Xin Liu. (2022) Erythrocyte Ghost Based Fusogenic Glycoprotein Vesicular Stomatitis Virus Glycoprotein Complexes as an Efficient Deoxyribonucleic Acid Delivery System. Journal of Biomaterials and Tissue Engineering 12:6, pages 1080-1086.
Crossref
Crossref
Silvia Minozzi, Theodore Lytras, Silvia Gianola, Marien Gonzalez-Lorenzo, Greta Castellini, Cristina Galli, Danilo Cereda, Stefanos Bonovas, Elena Pariani & Lorenzo Moja. (2022) Comparative efficacy and safety of vaccines to prevent seasonal influenza: A systematic review and network meta-analysis. eClinicalMedicine 46, pages 101331.
Crossref
Crossref
Neha Tiwari, Ernesto Rafael Osorio‐Blanco, Ana Sonzogni, David Esporrín‐Ubieto, Huiyi Wang & Marcelo Calderón. (2021) Nanocarriers for Skin Applications: Where Do We Stand?. Angewandte Chemie International Edition 61:3.
Crossref
Crossref
Neha Tiwari, Ernesto Rafael Osorio‐Blanco, Ana Sonzogni, David Esporrín‐Ubieto, Huiyi Wang & Marcelo Calderón. (2021) Nanocarriers for Skin Applications: Where Do We Stand?. Angewandte Chemie 134:3.
Crossref
Crossref
Hitesh Kumar Dewangan & Suman Tomar. (2022) Nanovaccine for transdermal delivery system. Journal of Drug Delivery Science and Technology 67, pages 102988.
Crossref
Crossref
Atin Khalaj-Hedayati, Caroline Lin Lin Chua, Peter Smooker & Khai Wooi Lee. 2022. Methods in Recombinant Protein Production. Methods in Recombinant Protein Production
45
89
.
Salvador F. Ausar, Nicholas R. Larson, Yangjie Wei, Akshay Jain & C. Russell Middaugh. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
79
135
.
Farrhana Ziana Firdaus, Mariusz Skwarczynski & Istvan Toth. 2022. Vaccine Design. Vaccine Design
145
178
.
Peter Walde & Sosaku Ichikawa. (2021) Lipid Vesicles and Other Polymolecular Aggregates—From Basic Studies of Polar Lipids to Innovative Applications. Applied Sciences 11:21, pages 10345.
Crossref
Crossref
Haiyue Xu, Lucy Cai, Stephanie Hufnagel & Zhengrong Cui. (2021) Intranasal vaccine: Factors to consider in research and development. International Journal of Pharmaceutics 609, pages 121180.
Crossref
Crossref
Laura Fernández, Jose Carlos Solana, Carmen Sánchez, Mª Ángeles Jiménez, Jose M. Requena, Rhea Coler, Steven G. Reed, Jesus G. Valenzuela, Shaden Kamhawi, Fabiano Oliveira, Epifanio Fichera, Reinhard Glueck, Maria Elena Bottazzi, Gaurav Gupta, Pedro Cecilio, Begoña Pérez-Cabezas, Anabela Cordeiro-da-Silva, Luigi Gradoni, Eugenia Carrillo & Javier Moreno. (2021) Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant. Microorganisms 9:11, pages 2253.
Crossref
Crossref
Kailash C. Petkar, Suyash M. Patil, Sandip S. Chavhan, Kan Kaneko, Krutika K. Sawant, Nitesh K. Kunda & Imran Y. Saleem. (2021) An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery. Pharmaceutics 13:4, pages 455.
Crossref
Crossref
Calogero Caruso, Anna Aiello, Graham Pawelec & Mattia Emanuela Ligotti. 2021. Human Aging. Human Aging
129
153
.
Mario Amacker, Charli Smardon, Laura Mason, Jack Sorrell, Kirk Jeffery, Michael Adler, Farien Bhoelan, Olga Belova, Mark Spengler, Beena Punnamoottil, Markus Schwaller, Olivia Bonduelle, Behazine Combadière, Toon Stegmann, Andrew Naylor, Richard Johnson, Desmond Wong & Sylvain Fleury. (2020) New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes. npj Vaccines 5:1.
Crossref
Crossref
Etsuro Nanishi, David J. Dowling & Ofer Levy. (2020) Toward precision adjuvants: optimizing science and safety. Current Opinion in Pediatrics 32:1, pages 125-138.
Crossref
Crossref
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2020. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids
285
315
.
Vijayan, Mohapatra, Uthaman & Park. (2019) Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials. Pharmaceutics 11:10, pages 534.
Crossref
Crossref
Shuting Shi, Haoru Zhu, Xinyu Xia, Zhihui Liang, Xuehu Ma & Bingbing Sun. (2019) Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity. Vaccine 37:24, pages 3167-3178.
Crossref
Crossref
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2018. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids
1
31
.
Nathalie Garçon & Martin Friede. 2018. Plotkin's Vaccines. Plotkin's Vaccines
61
74.e4
.
Pedro Cecílio, Begoña Pérez-Cabezas, Laura Fernández, Javier Moreno, Eugenia Carrillo, José M. Requena, Epifanio Fichera, Steven G. Reed, Rhea N. Coler, Shaden Kamhawi, Fabiano Oliveira, Jesus G. Valenzuela, Luigi Gradoni, Reinhard Glueck, Gaurav Gupta & Anabela Cordeiro-da-Silva. (2017) Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis. PLOS Neglected Tropical Diseases 11:11, pages e0005951.
Crossref
Crossref
Rebecca A.M. Blom, Mario Amacker, Christian Moser, R. Maarten van Dijk, Raffaela Bonetti, Emilie Seydoux, Sean R.R. Hall, Christophe von Garnier & Fabian Blank. (2017) Virosome-bound antigen enhances DC-dependent specific CD4+ T cell stimulation, inducing a Th1 and Treg profile in vitro. Nanomedicine: Nanotechnology, Biology and Medicine 13:5, pages 1725-1737.
Crossref
Crossref
Rebecca A. M. Blom, Mario Amacker, R. Maarten van Dijk, Christian Moser, Philip A. Stumbles, Fabian Blank & Christophe von Garnier. (2017) Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen. Frontiers in Immunology 8.
Crossref
Crossref
Charles B. Chesson, Shaunte Ekpo-Otu, Janice J. Endsley & Jai S. Rudra. (2016)
Biomaterials-Based Vaccination Strategies for the Induction of CD8
+
T Cell Responses
. ACS Biomaterials Science & Engineering 3:2, pages 126-143.
Crossref
Crossref
Mahfoozur Rahman, Sarwar Beg, Amita Verma, Firoz Anwar, Abdus Samad & Vikas Kumar. 2017. Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes. Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes
151
166
.
Birgit Weinberger. 2017. The Ageing Immune System and Health. The Ageing Immune System and Health
69
86
.
Christopher P. Karch & Peter Burkhard. (2016) Vaccine technologies: From whole organisms to rationally designed protein assemblies. Biochemical Pharmacology 120, pages 1-14.
Crossref
Crossref
Rebecca A. M. Blom, Silvia T. Erni, Kristína Krempaská, Olivier Schaerer, R. Maarten van Dijk, Mario Amacker, Christian Moser, Sean R. R. Hall, Christophe von Garnier & Fabian Blank. (2016) A Triple Co-Culture Model of the Human Respiratory Tract to Study Immune-Modulatory Effects of Liposomes and Virosomes. PLOS ONE 11:9, pages e0163539.
Crossref
Crossref
Kheshwant S. Gill, Philana Fernandes, Tracey R. O'Donovan, Sharon L. McKenna, Kishore K. Doddakula, Derek G. Power, Declan M. Soden & Patrick F. Forde. (2016) Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1866:1, pages 87-105.
Crossref
Crossref
Ana S Cordeiro & María J Alonso. (2016) Recent advances in vaccine delivery. Pharmaceutical Patent Analyst 5:1, pages 49-73.
Crossref
Crossref
J. Fleddermann, E. Diamanti, S. Azinas, M. Košutić, L. Dähne, I. Estrela-Lopis, M. Amacker, E. Donath & S. E. Moya. (2016) Virosome engineering of colloidal particles and surfaces: bioinspired fusion to supported lipid layers. Nanoscale 8:15, pages 7933-7941.
Crossref
Crossref
Katie R. Young, Guillaume Arthus-Cartier, Karen K. Yam, Pierre-Olivier Lavoie, Nathalie Landry, Marc-André D’Aoust, Louis-Philippe Vézina, Manon M.-J. Couture & Brian J. Ward. (2015) Generation and characterization of a trackable plant-made influenza H5 virus-like particle (VLP) containing enhanced green fluorescent protein (eGFP). The FASEB Journal 29:9, pages 3817-3827.
Crossref
Crossref
Gaëlle Vacher, Emmanuelle Sublet, Robert Gurny & Gerrit Borchard. (2015) Establishment and first characterization of a sublingual epithelial and immune cell co-culture model. International Journal of Pharmaceutics 482:1-2, pages 61-67.
Crossref
Crossref
Mark Spengler, Michael Adler & Christof M. Niemeyer. (2015) Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques. The Analyst 140:18, pages 6175-6194.
Crossref
Crossref
Ozan S. Kumru, Sangeeta B. Joshi, Dawn E. Smith, C. Russell Middaugh, Ted Prusik & David B. Volkin. (2014) Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies. Biologicals 42:5, pages 237-259.
Crossref
Crossref
Asghar Abdoli, Hoorieh Soleimanjahi, Masoumeh Tavassoti Kheiri, Abbas Jamali, Vahideh Mazaheri & Meghdad Abdollahpour Alitappeh. (2014) An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice. Pathogens and Disease, pages n/a-n/a.
Crossref
Crossref
Giuseppe Del Giudice & Rino Rappuoli. 2015. Influenza Pathogenesis and Control - Volume II. Influenza Pathogenesis and Control - Volume II
151
180
.
Steven G Reed, Mark T Orr & Christopher B Fox. (2013) Key roles of adjuvants in modern vaccines. Nature Medicine 19:12, pages 1597-1608.
Crossref
Crossref
Gaëlle Vacher, Matthias D. Kaeser, Christian Moser, Robert Gurny & Gerrit Borchard. (2013) Recent Advances in Mucosal Immunization Using Virus-like Particles. Molecular Pharmaceutics 10:5, pages 1596-1609.
Crossref
Crossref
Geert Leroux-Roels, Cathy Maes, Frédéric Clement, Frank van Engelenburg, Marieke van den Dobbelsteen, Michael Adler, Mario Amacker, Lucia Lopalco, Morgane Bomsel, Anick Chalifour & Sylvain Fleury. (2013) Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes. PLoS ONE 8:2, pages e55438.
Crossref
Crossref
Ursula Wiedermann, Adam B. Davis & Christoph C. Zielinski. (2013) Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines. Breast Cancer Research and Treatment 138:1, pages 1-12.
Crossref
Crossref
Martina Prelog. (2013) Differential Approaches for Vaccination from Childhood to Old Age. Gerontology 59:3, pages 230-239.
Crossref
Crossref
Nathalie. Garçon, Stanley. Hem & Martin. Friede. 2013. Vaccines. Vaccines
58
70
.
Juan Bárcena & Esther Blanco. 2013. Structure and Physics of Viruses. Structure and Physics of Viruses
631
665
.
Kimberly J. Hassett, Pradyot Nandi & Theodore W. Randolph. 2013. Sterile Product Development. Sterile Product Development
145
164
.
Christian Moser & Mario Amacker. 2013. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
287
307
.
Natasha Kushnir, Stephen J. Streatfield & Vidadi Yusibov. (2012) Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development. Vaccine 31:1, pages 58-83.
Crossref
Crossref
Gerd PluschkeMarco Tamborrini. (2012) Development of a virosomal malaria vaccine candidate: from synthetic peptide design to clinical concept validation. Future Virology 7:8, pages 779-790.
Crossref
Crossref
Teresa Lambe. (2012) Novel Viral Vectored Vaccines for the Prevention of Influenza. Molecular Medicine 18:8, pages 1153-1160.
Crossref
Crossref
Jean-Pierre Amorij, Gideon F.A. Kersten, Vinay Saluja, Wouter F. Tonnis, Wouter L.J. Hinrichs, Bram Slütter, Suzanne M. Bal, Joke A. Bouwstra, Anke Huckriede & Wim Jiskoot. (2012) Towards tailored vaccine delivery: Needs, challenges and perspectives. Journal of Controlled Release 161:2, pages 363-376.
Crossref
Crossref
Flavia De Bernardis, Mario Amacker, Silvia Arancia, Silvia Sandini, Christel Gremion, Rinaldo Zurbriggen, Christian Moser & Antonio Cassone. (2012) A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models. Vaccine 30:30, pages 4490-4498.
Crossref
Crossref
Carl R Alving, Kristina K Peachman, Mangala Rao & Steven G Reed. (2012) Adjuvants for human vaccines. Current Opinion in Immunology 24:3, pages 310-315.
Crossref
Crossref
G. Vacher, C. Gremion, C. Moser, S.A. Stoffel, M. Amacker, R. Zurbriggen, R. Gurny & G. Borchard. (2012) Virosomal C. albicans vaccine for vaginal application: formulation development and toxicity/immunogenicity studies. Journal of Drug Delivery Science and Technology 22:5, pages 447-452.
Crossref
Crossref
Luis J. Cruz, Paul J. Tacken, Felix Rueda, Joan Carles Domingo, Fernando Albericio & Carl G. Figdor. 2012. Nanomedicine - Infectious Diseases, Immunotherapy, Diagnostics, Antifibrotics, Toxicology and Gene Medicine. Nanomedicine - Infectious Diseases, Immunotherapy, Diagnostics, Antifibrotics, Toxicology and Gene Medicine
143
163
.
Jean C. Pfau. 2012. Immunotoxicity, Immune Dysfunction, and Chronic Disease. Immunotoxicity, Immune Dysfunction, and Chronic Disease
171
192
.
Rino Rappuoli & Ennio De GregorioChristian Moser. 2011. Novel Immunologic Adjuvants. Novel Immunologic Adjuvants
42
53
.
Silvia Minozzi, Theodore Lytras, Silvia Gianola, Marien Gonzalez-Lorenzo, Greta Castellini, Cristina Galli, Danilo Cereda, Stefanos Bonovas & Elena Pariani. (2021) Comparative Efficacy and Safety of Vaccines to Prevent Seasonal Influenza: A Systematic Review and Network Meta-Analysis. SSRN Electronic Journal.
Crossref
Crossref